Pacific Heights Asset Management LLC Has $7,829,000 Position in Agilent Technologies, Inc. (NYSE:A)
Pacific Heights Asset Management LLC continued to hold its stake in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 132,000 shares of the medical research company’s stock at the end of the second quarter. Pacific Heights Asset Management LLC’s holdings in Agilent Technologies were worth $7,829,000 at the end of the most recent reporting period.
A number of other hedge funds also recently modified their holdings of A. Skandinaviska Enskilda Banken AB publ increased its stake in Agilent Technologies by 5.7% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock valued at $3,428,000 after buying an additional 3,489 shares during the period. British Columbia Investment Management Corp increased its stake in Agilent Technologies by 96.7% in the first quarter. British Columbia Investment Management Corp now owns 357,983 shares of the medical research company’s stock valued at $18,927,000 after buying an additional 175,992 shares during the period. Garde Capital Inc. increased its stake in Agilent Technologies by 4.2% in the fourth quarter. Garde Capital Inc. now owns 13,341 shares of the medical research company’s stock valued at $608,000 after buying an additional 539 shares during the period. Wesbanco Bank Inc. acquired a new stake in Agilent Technologies during the first quarter valued at $215,000. Finally, Creative Planning increased its stake in Agilent Technologies by 6.3% in the first quarter. Creative Planning now owns 11,961 shares of the medical research company’s stock valued at $632,000 after buying an additional 710 shares during the period.
Shares of Agilent Technologies, Inc. (NYSE:A) traded down 0.40% during trading on Wednesday, hitting $60.30. The stock had a trading volume of 605,386 shares. The stock has a market cap of $19.38 billion, a price-to-earnings ratio of 33.90 and a beta of 1.30. The company’s 50 day moving average price is $60.03 and its 200 day moving average price is $54.38. Agilent Technologies, Inc. has a 12 month low of $42.92 and a 12 month high of $61.84.
Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.48 by $0.10. Agilent Technologies had a return on equity of 16.49% and a net margin of 13.41%. The company had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the business earned $0.44 EPS. Agilent Technologies’s revenue was up 8.1% on a year-over-year basis. Equities research analysts expect that Agilent Technologies, Inc. will post $2.23 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 26th. Shareholders of record on Monday, July 3rd will be issued a dividend of $0.132 per share. The ex-dividend date of this dividend is Thursday, June 29th. This represents a $0.53 annualized dividend and a yield of 0.87%. Agilent Technologies’s dividend payout ratio (DPR) is 29.78%.
WARNING: “Pacific Heights Asset Management LLC Has $7,829,000 Position in Agilent Technologies, Inc. (NYSE:A)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/07/26/pacific-heights-asset-management-llc-has-7829000-position-in-agilent-technologies-inc-nysea.html.
Several analysts have recently weighed in on the company. Wells Fargo & Company upgraded Agilent Technologies from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $42.92 to $60.73 in a research report on Wednesday, July 12th. BidaskClub upgraded Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, July 11th. Robert W. Baird lifted their target price on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 24th. Morgan Stanley reiterated an “overweight” rating on shares of Agilent Technologies in a research report on Monday, July 10th. Finally, Jefferies Group LLC lifted their target price on Agilent Technologies from $59.00 to $66.00 and gave the stock a “buy” rating in a research report on Tuesday, May 23rd. Two equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $60.12.
In other news, CEO Michael R. Mcmullen sold 32,511 shares of the stock in a transaction dated Monday, May 1st. The stock was sold at an average price of $55.48, for a total value of $1,803,710.28. Following the transaction, the chief executive officer now owns 260,346 shares in the company, valued at approximately $14,443,996.08. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Didier Hirsch sold 5,710 shares of the stock in a transaction dated Thursday, June 1st. The shares were sold at an average price of $60.60, for a total value of $346,026.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 150,119 shares of company stock worth $8,823,719.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.